Evidence map›Paper›PMID 39435128›Full record

ArticleFrontiers in psychiatry2024

Neurofeedback technique for treating male schizophrenia patients with impulsive behavior: a randomized controlled study.

Zhenkuo Li, Hao Ren, Yinghan Tian, Jiqian Zhou, Wenhao Chen, Guohua OuYang, Zhaolai Chen, Wei Yi, Hongli Song, Peng Xie and 4 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zhenkuo Li *Department of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Hao Ren *Department of Psychiatry, Chongqing Changshou District, Mental Health Center, Chongqing, China.
Yinghan Tian *Department of Psychiatry, Chaohu Hospital of Anhui Medical University, Hefei, China.
Jiqian ZhouDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Wenhao ChenDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Guohua OuYangDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Zhaolai ChenDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Wei YiDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Hongli SongDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Peng XieDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Xinchun WangDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Xi ChenDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Qinglin XiaoDepartment of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, China.
Huanzhong LiuDepartment of Psychiatry, Chaohu Hospital of Anhui Medical University, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Schizophrenia is one of the most severe mental disorders, frequently associated with aggression and violence, particularly in male patients. The underlying mechanisms of violent behavior in these patients remain unclear, limiting effective treatment options and highlighting the need for further research into interventions for impulsive behaviors. This study aims to evaluate the clinical efficacy of neurofeedback treatment in hospitalized male schizophrenia patients exhibiting impulsive behaviors. Methods: The study was designed as a single-center, randomized, single-blind, sham-controlled parallel trial. Eighty patients were randomly assigned to either a study group or a control group. The control group received risperidone and sham neurofeedback, while the study group received risperidone and active neurofeedback therapy. Both groups underwent training five times per week, with each session lasting 20 minutes, over a six-week period. Clinical symptoms were assessed at baseline, three weeks and six weeks using the Positive and Negative Syndrome Scale (PANSS), the Modified Overt Aggression Scale (MOAS), and the Rating Scale for Extrapyramidal Side Effects (RSESE). Statistical analyses were conducted to compare the therapeutic effects between the two groups at the study's conclusion. Results: Initial comparisons showed no significant differences in baseline data, except for the number of prior hospitalizations (P<0.018). By the end of the study, the study group demonstrate significant improvements in MOAS and PANSS scores (including the Excited, Positive, Cognitive, and Depressive/Anxiety Components), with no significant changes in RSESE scores. Discussion: Both time and group interactions were significant across most outcomes, underscoring the efficacy of neurofeedback in reducing the severity of impulsive behaviors and associated schizophrenia symptoms. Clinical trial registration: chictr.org.cn, identifier ChiCTR2200063407.

Indexed as

agitationimpulsivenessmaleneurofeedback therapyPANSS-excited componentschizophrenia

Identifiers

PMID39435128
PMCPMC11491364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.